Galapagos

NCT00905138

First-in-Human Single Ascending and Multiple Dose of GLPG0259

NCT00928343

First-in-Human Single Ascending Subcutaneous (s.c.) Dose and Single Oral Dose of GLPG0187

NCT00989703

GLPG0259 Multiple Ascending Dose and Methotrexate Drug-drug Interaction (DDI) in Healthy Subjects

NCT01024517

GLPG0259 Solid Formulation Bioavailability and Food Effect

NCT01023321

First-in-Human Single Ascending and Multiple Dose of GLPG0555

NCT01130818

First-in-Human Single Ascending Dose of GLPG0492

NCT01179581

First-in-Human Single Ascending and Multiple Dose of GLPG0634

NCT01208753

Pharmacokinetics/Pharmacodynamics (PK/PD) of Multiple Oral Doses of GLPG0555 in Healthy Subjects

NCT01322451

Oral Bioavailability of Two Solid Formulations of GLPG0259.

NCT01278108

First-in-Human Single Ascending and Multiple Dose of GLPG0778

NCT01278095

Oral Bioavailability of GLPG0555 in Different Solid Formulations

NCT01313598

GLPG0187: Safety, Tolerability and Pharmacokinetics in Patients With Solid Tumors

NCT01336244

GLPG0778: Multiple Ascending Oral Doses, Pharmacokinetic, Safety, and Pharmacodynamic Study

NCT01397370

Multiple Ascending Dose Study of GLPG0492 in Healthy Subjects

NCT01419990

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses of GLPG0634 in Healthy Subjects

NCT01496937

First-in-Human Exploratory Single Ascending Dose of GLPG0974

NCT01538420

GLPG0492 Pharmacodynamics

NCT01580644

Bioavailability Study of Prodrug of GLPG0187 in Healthy Volunteers

NCT01665924

Single and Multiple Dose Pharmacokinetics of GLPG0634 in Elderly Healthy Subjects

NCT01721980

Multiple Ascending Dose Study of GLPG0974 in Healthy Subjects

NCT01798979

A Phase I, Open Interaction Study Between GLPG0634 and Midazolam in Healthy Subjects

NCT01820806

Investigation of the Pharmacokinetics and Metabolism of GLPG0634 in Healthy Male Subjects

NCT01887106

First-in-Human Single and Multiple Dose of GLPG1205

NCT01915667

Oral Bioavailability of Two Solid Formulations of GLPG0634

NCT02084199

Study to Evaluate GLPG0634 in Subjects With Renal Impairment Compared to Healthy Subjects

NCT02143856

Oral Bioavailability of Solid Formulation of GLPG1205 With and Without Food

NCT02162355

Multiple Ascending Dose Study of GLPG0634 in Japanese and Caucasian Healthy Subjects

NCT02179502

First-in-Human Single and Multiple Dose of GLPG1690

NCT02325037

First-in-Human Single and Multiple Dose of GLPG1837

NCT02562859

Oral Bioavailability of Solid Formulation of GLPG1837 With and Without Food

NCT02562950

A Phase I, Open Interaction Study Between GLPG1837 and Midazolam in Healthy Male Subjects

NCT02623296

A Drug-drug Interaction Study Between GLPG1205 and a Cocktail of CYP450 Substrates in Healthy Male Subjects

NCT02612246

First-in-Human Single and Multiple Dose of GLPG1972

NCT02662452

First-in-Human Single and Multiple Dose of GLPG2222

NCT02788721

A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2451 in Healthy Female Subjects

NCT02739009

First in Human of Single and Multiple Doses of MOR106

NCT02851485

Bioavailability Study With GLPG1972

NCT03102567

This is a Study to Evaluate the Effect of Aging of Multiple Doses of GLPG1205 in Healthy Subjects

NCT03214614

A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2451 in Healthy Male Subjects

NCT03410979

A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2737 in Healthy Subjects

NCT03128606

A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG3067 in Healthy Subjects.

NCT03143725

Study to Compare Bioavailability of GLPG1972 Given as 2 Different Tablet Formulations Versus an Oral Solution

NCT03143712

Study to Assess Bioavailability of GLPG1690 Given as Oral Capsule or Tablet

NCT03311009

A Study With GLPG1972 in Osteoarthritis Subjects

NCT03450720

Pharmacokinetics of GLPG2737 in Male Subjects With Cystic Fibrosis

NCT03589313

Pharmacokinetics of GLPG3067 in Male Subjects With Cystic Fibrosis.

NCT03515382

A Study in Healthy Male Volunteers to Look at How the Test Medicine GLPG1690 is Taken up by the Body When Doses of Itraconazole and Voriconazole Are Given to Healthy Volunteers

NCT03417778

Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function

NCT03540524

A Study Looking at the Safety, Tolerability and Efficacy of the Combination of the Study Drugs GLPG2451 and GLPG2222 With or Without GLPG2737 in Patients With Cystic Fibrosis.

NCT03689829

A Study to Test Safety, Tolerability, and the Way the Body Absorbs, Distributes, and Gets Rid of a Study Drug Called MOR106, in Healthy Subjects and in Patients With Moderate to Severe Atopic Dermatitis

NCT03787186

A Study in Healthy Male Volunteers to Look at How the Test Medicine GLPG1690 is Taken up by the Body When Given by Mouth and Into a Vein as an Injection

NCT03800472

A Study Investigating the Safety, Absorption and Elimination of GLPG3312, a New Drug in the Treatment of Inflammatory Diseases

NCT03899909

A Study to Evaluate the Effects of a Single and Multiple Oral Doses of GLPG3121 in Adult, Healthy, Male Subjects

NCT04106297

A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3970

NCT04136327

A Study in Healthy Male Volunteers to Test How the Test Medicine GLPG1972 is Taken up by the Body When Given by Mouth and Into the Vein as an Injection

NCT04097938

A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3667

NCT04137341

A Study in Healthy Volunteers to Compare Different Tablet Formulations of the Test Medicine, GLPG1972, Against the Current Tablet Formulation, and to Assess the Effect Food Has on One of the Test Medicines

NCT04532567

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GLPG1205 in Healthy Japanese and Caucasian Male Subjects

NCT04575818

A Study in Healthy Male Volunteers Investigating the Safety, Absorption and Elimination of Single Doses of GLPG4059

NCT04594928

A Study Evaluating the Effects of GLPG3667 Given as an Oral Treatment for 4 Weeks in Adults With Moderate to Severe Plaque Psoriasis

NCT04608344

Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy Participants

NCT04653467

A Study to Evaluate How Well Single and Multiple Doses of GLPG4399 Are Tolerated in Healthy, Adult Subjects

NCT04700267

A Study Evaluating the Effects of GLPG3970 Given as Oral Treatment for 12 Weeks in Adults With Systemic Lupus Erythematosus

NCT04708184

A Study to Assess Relative Bioavailability of and Effect of Food on a New Oral Tablet Formulation of GLPG3970

NCT04720183

Drug-drug Interaction Study with GLPG3970 and Sulfasalazine in Adult, Healthy Subjects

NCT04704739

Evaluation of Mass Balance and Absolute Bioavailability of GLPG1205

NCT04736927

Drug-drug Interaction Study With GLPG3667 and Midazolam in Healthy Subjects

NCT04856358

A Study to Evaluate How Well Single and Multiple Doses of GLPG3121-modified Release Formulation Are Tolerated in Healthy, Adult Subjects

NCT04907149

Evaluation of Mass Balance and Absolute Bioavailability of GLPG3970

NCT04971746

Drug-drug Interaction Study with GLPG4716 and Nintedanib and Pirfenidone in Healthy Subjects

NCT04976270

A Study to Evaluate How Well Single and Multiple Doses of GLPG3667 Are Tolerated in Healthy, Adult Subjects

NCT05030857

Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects

NCT05272683

Drug-drug Interaction Study with GLPG3667 and Itraconazole in Healthy Subjects

NCT05335447

Evaluation of Mass Balance and Absolute Bioavailability of GLPG3667

NCT06043739

Relative Bioavailability and Effect of Food Study With an Oral Mini-tablet Formulation of Filgotinib in Healthy Subjects